Institut für Pneumologie Hagen Ambrock eV
15
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Evaluation of the Multidimensional Dyspnea Profile (MDP)
Role: lead
Nasal High Flow (NHF) in COPD - Effects on Ventilation in Wakefulness
Role: lead
Comparison of Sleep Disordered Breathing Events Detected by the CPAP Device "prismaLine" With Polysomnography
Role: lead
The Effects of Airtrapping on Sleep and Breathing in Non Invasive Ventilation (NIV) in COPD
Role: lead
Improvement of Sleep Quality by RePneu® Coils in Advanced Pulmonary Emphysema
Role: lead
Efficacy and Physiology of Nasal High Flow Therapy
Role: lead
Telemonitoring of CPAP Therapy in Apoplexy Patients With OSA
Role: lead
Effects of Ergometer Training With Telemonitoring in Patients With Chronic Obstructive Pulmonary Disease (COPD) After Exacerbation
Role: lead
Intelligent Volume Assured Pressure Support to Improve Sleep Quality and Respiratory Events in Patients With Non Invasive Ventilation
Role: lead
Respiratory Physiology Under High Flow Therapy
Role: lead
Arousal Analysis by Pulse Wave Amplitude in Patients With Obstructive Sleep Apnea
Role: lead
Divided Attention Steering Simulator Alertness Test
Role: lead
Nocturnal Transnasal Insufflation (nTNI)
Role: lead
Ergometer Training in Patients With OSA
Role: lead
Humidity Under Continuous Positive Airway Pressure
Role: lead
All 15 trials loaded